Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1378847
PUBLISHER: IMARC | PRODUCT CODE: 1378847
Pharmerging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Abstract
The global pharmerging market size reached US$ 1.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.2 Billion by 2028, exhibiting a growth rate (CAGR) of 12.2% during 2022-2028.
Pharmerging refers to a group of countries that hold low positioning in the pharmaceutical market but have a speedy growth. Some of the key pharmerging markets include China, India, Brazil, Russia, South Africa, Mexico, Indonesia, Turkey, etc.
The increasing healthcare expenditures along with the rising number of private hospitals are currently propelling the global pharmerging market growth. Additionally, the high prevalence of numerous chronic diseases and growing consumer awareness towards early disease detection and treatment procedures are further augmenting the market growth. Moreover, the increasing geriatric population, who are more prone to serious medical conditions, such as dementia, hypertension, cardiac failure, etc., is also bolstering the demand for pharmaceuticals. Additionally, the introduction of government policies and reimbursement schemes across various countries for reducing the cost of treatment for chronic diseases is also propelling the market growth. Moreover, the growing number of insurance companies in the pharmerging countries offering numerous insurance policies to decrease the out-of-the-pocket expenditures is further augmenting the demand of pharmaceuticals in these countries. Apart from this, the rising investments in extensive R&D activities in the fields of biotechnology, immunology, oncology, etc., for the introduction of advanced treatments are also catalyzing the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmerging market report, along with forecasts at the global and country level from 2023-2028. Our report has categorized the market based on product, indication and distribution channel.
Breakup by Product:
Pharmaceuticals
Patented Prescription Drugs
Generic Prescription Drugs
OTC Drugs
Healthcare
Medical Devices
Clinical Diagnosis
Others
Breakup by Indication:
Lifestyle Diseases
Cancer and Autoimmune Diseases
Infectious Diseases
Others
Breakup by Distribution Channel:
Hospitals
Retail Pharmacies
Online Stores
Others
Breakup by Country:
Tier I
China
Tier II
India
Brazil
Russia
South Africa
Tier III
Argentina
Mexico
Poland
Ukraine
Turkey
Saudi Arabia
Egypt
Algeria
Nigeria
Thailand
Indonesia
Pakistan
Others
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Sanofi S.A., Pfizer Inc., AstraZeneca Plc, GlaxoSmithKline Plc, F. Hoffmann-La Roche AG (Roche AG), Eli Lilly and Company, Johnson & Johnson, Abbott Laboratories, Novartis AG and Teva Pharmaceutical Limited.
Key Questions Answered in This Report:
- How has the global pharmerging market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What is the impact of COVID-19 on the global pharmerging market?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the indication?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the market?
- What is the structure of the global pharmerging market and who are the key players?
- What is the degree of competition in the market?
Product Code: SR112023A3441
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Pharmerging Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Pharmaceutical
- 6.1.1 Market Trends
- 6.1.2 Major Types
- 6.1.2.1 Patented Prescription Drugs
- 6.1.2.2 Generic Prescription Drugs
- 6.1.2.3 OTC Drugs
- 6.1.3 Market Forecast
- 6.2 Healthcare
- 6.2.1 Market Trends
- 6.2.2 Major Types
- 6.2.2.1 Medical Devices
- 6.2.2.2 Clinical Diagnosis
- 6.2.2.3 Others
- 6.2.3 Market Forecast
7 Market Breakup by Indication
- 7.1 Lifestyle Diseases
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Cancer and Autoimmune Diseases
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Infectious Diseases
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Retail Pharmacies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Online Stores
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Country
- 9.1 Tier I
- 9.1.1 China
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.1 China
- 9.2 Tier II
- 9.2.1 India
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Brazil
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 Russia
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Africa
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.1 India
- 9.3 Tier III
- 9.3.1 Argentina
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 Mexico
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 Poland
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Ukraine
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Turkey
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Saudi Arabia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Egypt
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.8 Algeria
- 9.3.8.1 Market Trends
- 9.3.8.2 Market Forecast
- 9.3.9 Nigeria
- 9.3.9.1 Market Trends
- 9.3.9.2 Market Forecast
- 9.3.10 Thailand
- 9.3.10.1 Market Trends
- 9.3.10.2 Market Forecast
- 9.3.11 Indonesia
- 9.3.11.1 Market Trends
- 9.3.11.2 Market Forecast
- 9.3.12 Pakistan
- 9.3.12.1 Market Trends
- 9.3.12.2 Market Forecast
- 9.3.13 Others
- 9.3.13.1 Market Trends
- 9.3.13.2 Market Forecast
- 9.3.1 Argentina
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Sanofi S.A.
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 Pfizer Inc.
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.2.4 SWOT Analysis
- 13.3.3 AstraZeneca Plc.
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.3.4 SWOT Analysis
- 13.3.4 GlaxoSmithKline Plc.
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 F. Hoffmann-La Roche AG (Roche AG)
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.5.4 SWOT Analysis
- 13.3.6 Eli Lilly and Company
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.6.4 SWOT Analysis
- 13.3.7 Johnson & Johnson
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.7.4 SWOT Analysis
- 13.3.8 Abbott Laboratories
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.8.3 Financials
- 13.3.8.4 SWOT Analysis
- 13.3.9 Novartis AG
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.9.3 Financials
- 13.3.9.4 SWOT Analysis
- 13.3.10 Teva Pharmaceutical Limited
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.10.3 Financial
- 13.3.10.4 SWOT Analysis
- 13.3.1 Sanofi S.A.
Product Code: SR112023A3441
List of Figures
- Figure 1: Global: Pharmerging Market: Major Drivers and Challenges
- Figure 2: Global: Pharmerging Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Pharmerging Market: Breakup by Product (in %), 2022
- Figure 4: Global: Pharmerging Market: Breakup by Indication (in %), 2022
- Figure 5: Global: Pharmerging Market: Breakup by Distribution Channel (in %), 2022
- Figure 6: Global: Pharmerging Market: Breakup by Country (in %), 2022
- Figure 7: Global: Pharmerging Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 8: Global: Pharmerging (Pharmaceuticals) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 9: Global: Pharmerging (Pharmaceuticals) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 10: Global: Pharmerging (Healthcare) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: Pharmerging (Healthcare) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: Pharmerging (Lifestyle Diseases) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: Pharmerging (Lifestyle Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: Pharmerging (Cancer and Autoimmune Diseases) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: Pharmerging (Cancer and Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: Pharmerging (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: Pharmerging (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: Pharmerging (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: Pharmerging (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: Global: Pharmerging (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: Global: Pharmerging (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Global: Pharmerging (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Global: Pharmerging (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: Global: Pharmerging (Online Stores) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: Global: Pharmerging (Online Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: Global: Pharmerging (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: Global: Pharmerging (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: Tier I: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: Tier I: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 30: China: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 31: China: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 32: Tier II: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 33: Tier II: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 34: India: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 35: India: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 36: Brazil: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 37: Brazil: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 38: Russia: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 39: Russia: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 40: South Africa: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 41: South Africa: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 42: Tier III: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 43: Tier III: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 44: Argentina: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 45: Argentina: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 46: Mexico: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 47: Mexico: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 48: Poland: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 49: Poland: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 50: Ukraine: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 51: Ukraine: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 52: Turkey: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 53: Turkey: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 54: Saudi Arabia: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 55: Saudi Arabia: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 56: Egypt: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 57: Egypt: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 58: Algeria: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 59: Algeria: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 60: Nigeria: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 61: Nigeria: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 62: Thailand: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 63: Thailand: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 64: Indonesia: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 65: Indonesia: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 66: Pakistan: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 67: Pakistan: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: Others: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
- Figure 69: Others: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 70: Global: Pharmerging Industry: SWOT Analysis
- Figure 71: Global: Pharmerging Industry: Value Chain Analysis
- Figure 72: Global: Pharmerging Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Pharmerging Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Pharmerging Market Forecast: Breakup by Product (in Million US$), 2023-2028
- Table 3: Global: Pharmerging Market Forecast: Breakup by Indication (in Million US$), 2023-2028
- Table 4: Global: Pharmerging Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
- Table 5: Global: Pharmerging Market Forecast: Breakup by Country (in Million US$), 2023-2028
- Table 6: Global: Pharmerging Market: Competitive Structure
- Table 7: Global: Pharmerging Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.